Resources from the same session
LBA41 - Phase II study SECOMBIT (sequential combo immuno and target therapy study): 4-years OS data and preliminary biomarkers evaluation
Presenter: Paolo Ascierto
Session: Mini Oral session: Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
LBA42 - Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma
Presenter: Sungjune Kim
Session: Mini Oral session: Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
790MO - Phase I study of fianlimab, a human lymphocyte activation gene-3 (LAG-3) monoclonal antibody, in combination with cemiplimab in advanced melanoma (mel)
Presenter: Omid Hamid
Session: Mini Oral session: Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
791MO - Clinical and tumor characteristics of patients (pts) with recurrence after pathologic response upon neoadjuvant ipilimumab (IPI) + nivolumab (NIVO) in stage III melanoma
Presenter: Judith Versluis
Session: Mini Oral session: Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
LBA43 - Intradermal IMO-2125 versus placebo as adjuvant treatment in patients with stage II pT3-4/cN0 melanoma: Interim efficacy and safety results of the randomized phase II INTRIM study
Presenter: Jessica Notohardjo
Session: Mini Oral session: Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
LBA44 - Pembrolizumab versus placebo after complete resection of high-risk stage III melanoma: Long-term quality of life analysis results of the EORTC 1325-MG/Keynote-054 double-blinded phase III trial
Presenter: Alexander Eggermont
Session: Mini Oral session: Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
792MO - Neoadjuvant pepinemab in combination with nivolumab and/or ipilimumab in resectable stage III melanoma
Presenter: Michael Lowe
Session: Mini Oral session: Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
Invited Discussant 791MO, LBA43, LBA44 and 792MO
Presenter: Omid Hamid
Session: Mini Oral session: Melanoma and other skin tumours
Resources:
Slides
Webcast